Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?

To: Paul Senior who wrote (35728)	10/20/2009 7:43:10 AM
From: Paul Lee	Read Replies (1) \| Respond to of 78741

"So for me to buy this stock, even in my small spec plays, I have to believe in Dyloject, maybe even be an expert in it, or else I have to believe in others who believe in it - the ceo and/or the article author. " Paul, there is not that much to believe in. Dyloject has already been approved in Great Britain and they have a major parter who is working to expand it thru pout Europe. It will shortly file in the US. The drug as been used for year so approval is almost assured (as much as can be). Plus they have to other drugs in the phase 3 category. And trust me when he says the shareholders are frustrated, but that will change, soon.